MORRISVILLE, N.C., mai 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health^® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced that the Company is scheduled to present at two upcoming investor conferences:

• Chief Executive Officer Alistair Macdonald is scheduled to present at the Jefferies Virtual Healthcare Conference on mercredi, juin 2, 2021, at 8:30 a.m. ET.
• Chief Financial Officer Jason Meggs is scheduled to present at the Goldman Sachs 42nd Annual Global Healthcare Conference on mercredi, juin 9, 2021, at 3:00 p.m. ET.

A live webcast of each event, along with a link to the presentation materials and archived audio replay of each presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com.

About Syneos Health
Syneos Health^® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 25,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Ensemble, nous partageons des connaissances, utilisons les dernières technologies et appliquons des pratiques commerciales de pointe pour accélérer la livraison d’importants traitements par nos clients aux patients. To learn more about how we are Shortening the distance from lab to life^®, visit syneoshealth.com or subscribe to our podcast.